US Edition
The FDA Plans to Limit Access to Covid Vaccines. Here’s Why that’s Not All Bad.
- The FDA plans to limit COVID-19 vaccine booster access this fall, approving them primarily for people over 65 and those with risk factors in the U.S.
- This policy shift follows concerns about uncertain clinical evidence supporting boosters for healthy people under 65, prompting the FDA to require randomized trial data before approval.
- Experts note the new FDA framework aligns with some international policies, but many criticize it for lacking transparency and possibly restricting access to vaccines for millions of healthy Americans.
- Dr. Vinay Prasad described annual boosters as a "public health disaster," while other experts warn limiting access without proper insurance coverage might force some to pay out-of-pocket or forgo vaccination.
- This change could reduce vaccination rates among healthy populations and raise concerns about balancing public health needs with scientific rigor during the transition from emergency to routine COVID management.
14 Articles
14 Articles
Why Black America Should Be Concerned COVID-19 Vaccine Will be Harder To Get
The U.S. Food and Drug Administration’s decision to limit COVID vaccines to people 65 and older and others with underlying health conditions has alarmed some medical experts who worry the change will lead to more infections and more deaths.Read more...
The FDA plans to limit access to covid vaccines. Here’s why that’s not all bad.
This week, two new leaders at the US Food and Drug Administration announced plans to limit access to covid vaccines, arguing that there is not much evidence to support the value of annual shots in healthy people. New vaccines will be made available only to the people who are most vulnerable—namely, those over 65 and others with conditions that make them more susceptible to severe disease. Anyone else will have to wait. Covid vaccines will soon b…
How the FDA Might Make It Harder to Get COVID Shots This Year
The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall, but FDA officials published a policy position in the New England Journal of Medicine announcing that it intends to make some drastic policy changes.
FDA Panel is Split on Updates to COVID Shots as Questions Loom for Fall Vaccinations
Get latest articles and stories on World at LatestLY. Government advisers were split Thursday on whether drugmakers need to update their COVID-19 vaccines for next season, a decision overshadowed by confusion over a new Trump administration policy that may limit which Americans can get the shots. World News | FDA Panel is Split on Updates to COVID Shots as Questions Loom for Fall Vaccinations.
FDA Has Changed Covid Vaccine Policy, Some Fear Decreased Access & Uptake
ProfessionalStudioImages/E+/Getty ImagesEarlier this week, the Food & Drug Administration (FDA) — under the auspices of the Department of Health and Human Services (HHS) — announced that it will be drastically pulling back on recommending seasonal vaccination for COVID-19. Until now, annual vaccination was recommended for all Americans six months and older to be better protected from COVID-19 variants. Now, in a paper published in The New Englan…
Coverage Details
Bias Distribution
- 56% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
